XML 51 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements - Assets/Liabilities Measured at Fair Value (Details) - USD ($)
shares in Thousands, $ in Thousands
Oct. 30, 2020
Dec. 31, 2022
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Cash and cash equivalents   $ 23,774 $ 21,100
Quoted Price in Active Markets for Identical Instruments Level 1      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Cash and cash equivalents   307 82
Significant Other Observable Inputs Level 2      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Cash and cash equivalents   23,467 21,018
Significant Unobservable Inputs Level 3      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Cash and cash equivalents   0 0
Processa Pharmaceuticals, Inc      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Processa common shares   56 240
Processa Pharmaceuticals, Inc | Quoted Price in Active Markets for Identical Instruments Level 1      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Processa common shares   56  
Processa Pharmaceuticals, Inc | Significant Other Observable Inputs Level 2      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Processa common shares     240
Processa Pharmaceuticals, Inc | Significant Unobservable Inputs Level 3      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Processa common shares   $ 0 $ 0
License agreement | Processa Pharmaceuticals, Inc | Restricted shares      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Shares to be issued under agreement 41    
License agreement | Processa Pharmaceuticals, Inc | Restricted shares | 6 month interval      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Expiration of share restriction 50.00%    
Share Restriction Term 6 months    
License agreement | Processa Pharmaceuticals, Inc | Restricted shares | 9 month interval      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Expiration of share restriction 25.00%    
Share Restriction Term 9 months    
License agreement | Processa Pharmaceuticals, Inc | Restricted shares | 12 month interval      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Expiration of share restriction 25.00%    
Share Restriction Term 12 months